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How Positionally Stable is a Transesophageal
Echo Probe During 3 Dimensional Imaging?
Implications for 3 Dimensional Reconstruction
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Conclusion' Probe movement during 3D imaging is measurable and in
these anesthetized subjects was within acceptable limits. This capability will
be useful in awake patients where greater movement is expected, and will
optimize the 3D data set by discarding scans where significant probe move-
ment has occurred.
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We have recently shown that lidocaine (lido) significantly reduces infarct size
in the rabbit model of Myocardial Reperfusion Injury IMRI). In that study
rabbits (n = 22) underwent 30 mins of circumflex occlusion and 48 hrs of
reperfusion and where randomized in a blinded fashion to receive lido (n =
11, 4 boluses of 10 mglkg in the first 10 mins of ischemia) or saline (n =
11). Lido reduced infarct size by approximately 50% (p < 0.01) of the area
at risk. The present study further examines possible mechanisms for this
beneficial effect. We studied the reperfused myocardium of both groups in
a blinded fashion for histologic changes including the degree of neutrophil
infiltration (PMN). hemorrhage (Hemo) and contraction bands (Band). Asso-
ciated with the reduction on infarct size, lido inhibited the PMN infiltration
and hemorrhage in these hearts. We next examined the effects of lido ex
vivo on PM N activation by chemiluminescence in whole blood. A significant
reduction in the chemiluminescence response to the chemoattractant FMLP
was obtained with rabbit and human blood. Chemiluminescence results ex-
pressed as percent inhibition of FMLP response. Mean ± SEM:
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image of inner surface reconstruction. In conclusion, these results suggest
that 3D-TEE has advantages in estimation of the surface morphology, spa-
tial extent and actual location of aortic abnormalities and limitations in tissue
characterization.
Inhibition of Neutrophil Function by Lidocaine as a
Mechanism for the Beneficial Effect to Reduce
Myocardial Reperfusion Injury
Joao V. Vitola, John P. Holsinger, James Atkinson, Mervyn B. Forman, John
J. Murray. Vanderbilt University, Nashville, TN
Malcolm E. Legget, RoyW Martin, Florence H. Sheehan, Gerry Bashein, Edward
l. Bolson, Xian-Ning Li, Todd R. Zwink, Catherine M. Otto. University of Washington,
Seattle, WA
Three dimensional (3D) reconstruction from a single esophageal scanning
position requires a stable relationship between the probe and the heart. The
purpose of this study was to examine the movement of a transesophageal
echo ITEE) probe during 3D image acquisition. A new dual axis multiplane
probe was used which includes a miniature (6 x 6 x 9 mm) 60 sensor in the
tip. The sensor identifies the probe's 3D position and orientation in space
with respect to the location of a magnetic field generator placed beneath
the subject. In vivo 3D scans were performed in 5 anesthetized, ventilated
dogs. Positional determinations were acquired every 66 ms. The sensor axes
were: x-mediolateral. y-superoinferior, z-anteroposterior, and r-radial distance
~ .Jlx2 + y2 + z2). The movement was estimated by computing standard
deviations of the x, y, and z positions during each 3D scan and each cardiac
cycle. From 2337 determinations, the mean standard deviation for 10 3D
scans and 264 cardiac cycles and histograms of the radial movement were
calculated and are shown.
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Comparison of the Mitral Annulus in Normals and
Patients with Cardiomyopathy by Dynamic
Three-dimensional Reconstruction from
Transesophageal Echocardiograms
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Aortic Inner Surface Morphology in Aortic
Disease by Three-Dimensional Transesophageal
Echocardiography: Its Advantages and
Limitations for Diagnosis
Makoto Matsumura, Elina Yamada, Chifumi Takayama, Shunei Kyo,
Toshiyuki Matsunaka, Sousuke Kimura, Ryozo Omoto. Saitama Medical School,
Saitama, Japan
three-dimensional (3-D) analysis of mitral annular configuration and dynam-
ics in patients with an annuloplasty ring has not been reported. Introduction
of multiplane transesophageal echocardiography (M-TEE) provides 3-D re-
construction of the mitral annulus from multiple cross-sectional views from
a stable transducer position by rotating around a central axis. Therefore, we
evaluated the effect of the annuloplasty ring on mitral annular configuration
and dynamics by using M-TEE 3-D reconstruction. Six patients with a flexi-
ble Duran ring and 6 with a rigid Carpentier ring who underwent mitral valve
repair for mitral regurgitation were examined by M-TEE.
Results; In patients with a flexible Duran ring, the annulus had a nonpla-
nar configuration and the annular area changed during the cardiac cycle. The
percentage reduction in the annular area in these patients was 24 ± 5%. In
patients with a rigid Carpentier ring, however, the annulus had planar config-
uration and the annular area did not change during the cardiac cycle.
Conclusion' 3-D reconstruction of the mitral annulus by M-TEE revealed
that mitral annular configuration and dynamics are physiological in patients
with a flexible Duran ring compared with a rigid Carpentier ring.
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To compare shape and dynamic behavior of the mitral annulus (MAl in nor-
mals (N) and patients (pts) with cardiomyopathy, multiplane transesophageal
echos (MTEE) from seven pts with hypertrophic obstructive (HOCM) and five
with dilative cardiomyopathy IDCM) were compared to 10 N. Methods; The
mitral valve was imaged from a stable transducer position in 12 planes 15"
apart each; MA points were identified in each frame of one cardiac cycle and
reconstructed in space and time. Shape, apico-basal translation (AB), mini-
mal area and cyclic area change (l>A) were analyzed using a least squares
plane fitted to MA for each frame. Results; Significant differences were de-
tected between the three groups. Mean AB was higher in Nand HOCM than
in OCM (11,8, and 4 mm, respectively; p < 0.02); minimal areas were lower
in HOCM than in DCM or N (p < 0.05), while mean l>A was higher in HOCM
than in Nand DCM Ip < 0.05).
Conclusion; dynamic three-dimensional reconstruction of MTEE images
allows detailed quantitative analysis of MA shape and behavior in normals,
HOCM and DCM.
The purpose of this study was to evaluate the inner surface morphology of
the aorta in different pathologies using three-dimensional transesophageal
echocardiography (3D-TEE), and to clarify its feasibility and limitations for
clinical application. Two-dimensional TEE was performed in 20 patients with
aortic disease (12 aortic dissection, 4 aortic aneurysm, 4 aortic sclerosis) and
7 with normal aorta. Transverse view of the descending aorta was taken at
each 2 mm interval by manually withdrawing the probe. Each image was
recorded in VTR during one beat. Off-line data analysis was performed and
3D image was reconstructed using Lambert shading method. In 8 cases with
DeBakey type III aortic dissection who had the entry or reentry and flow in
the false lumen, 3D-TEE could demonstrate the irregularity on the shape of
intimal tear and the wavy movement of flap, and clarify the accurate location
of the intimal tear and the transverse and longitudinal extent of the dissect-
ing flap in all cases. These coincided with the operating findings in 3 cases
underwent surgical treatment. On the other hand, the image of inner surface
area in 4 cases that the false lumen was filled with thrombus, could not be dif-
ferentiated from a normal aorta. In cases with aortic aneurysm or atheroscle-
rosis it was possible to visualize the spatial morphology of the aneurysm or
plaque and determine its extension. However, nature of the plaque (soft or
hard) and intramural thrombus (fresh or old), could not be estimated by the
1922-591
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'p < 0.05, "p ~ 0.01 (Student's t test L-C vs PI)
fied by the detergent pluronic F-68 and a variety of lipids, significantly re-
duces myocardial reperfusion injury (RI) in animals and humans as shown in
some initial clinical trials. Potential mechanisms for Fluosol include enhanced
O2 delivery to the reperfused tissue and modulation of various neutrophil
(PMNs) functions. Recent studies in dogs and man demonstrate the same
beneficia: effect for treatment of Rl with the detergent component alone,
RheothRx, which is currently undergoing clinical trials. We have shown that
the effect of Fluosol on PM Ns is related to this detergent. However, pro-
longed infusion (48 hrs) of detergent is required to reduce Rl to the same
extent as Fluosol given over only 1 hr. Possible mechanisms for the benefi-
cial effects of Fluosol (02 delivery vs effects on PMNs) were investigated in
a model of regional ischemia utilizing rabbits undergoing 30 mins of circum-
flex occlusion and 48 hrs of reperfusion. Infarct size (area of necrosis, AN)
was determined histologically and expressed as percent of risk region (area
at risk, AR). Animals received Fluosol (30 cc/kg) with or without 02 or saline
over the first 60 mins of reperfusion. AR was similar in all groups. (Mean ±
SEM of AN/AR (%), n ~ 11 for all groups). The treatment with Fluosol with or
without 02 (44 ± 3 and 40 ± 3, respectively) was significantly (p < 0.05) re-
duced compared to control (63 ± 4). Another group received F-I08, a larger
size pluronic detergent found to be 2.5-fold more potent in suppressing PMN
function in vitro compared to F-68, during the first 3 hrs of reperfusion. This
treatment did not alter the infarct size (63 ± 5). RheothRx was found to form
4 nm micelles in solution whereas Fluosol formed particles approximately
100 times larger. Similar sized particles were formed by substituting the per-
fluorocarbons with mineral oil. The in vitro activity of this pluronic/mineral oil
micelle on PMN function was similar to Fluosol. Infusion of these larger oil
micelles was tolerated by rabbits and used in further infarct studies. Con-
clusions; These studies suggest that (1) reduction of RI by Fluosol is not
due to enhanced 02 delivery by the PFCs to reperfused myocardium and (2)
since the Fluosol emulsion markedly reduces the clearance of the detergent
F-68 (tv,: Fluosol ~ 8 hrs vs RheothRx ~ 1.5 hrs). prolonged PMN suppres-
sion rather than potency of suppression is the mechanism whereby Fluosol
ameliorates RI. FluosoJ's clinical efficacy may be enhanced by prolonging its
infusion to ensure an adequate blood level to suppress PMN function be-
yond the time of reperfusion injury. RheothRx's clinical usefulness may be
facilitated by decreasing its renal clearance by delivering larger micelles of
the detergent in order to produce prolonged PMN suppression with a shorter
infusion time.
Predictors of Early Recovery in Left Ventricular
Function After Primary Angioplasty in Acute
Myocardial Infarction
Luiz A. Mattos, Fausto Feres, Luiz F. Tanajura, Ibraim Pinto, Aurea Chaves,
Marinella Centemero, Gilberta Nunes, Amanda Sousa, J. Eduardo Sousa. Dante
Pazzanese Institute of Cardiology, Sao Paulo. Brazil
Clinical and angiographic data were analysed in 244 pts submitted to a suc-
cessful primary PTCA within 24 hrs of acute MI to determine predictors of
early recovery in LV function. All pts had a LV angiogram before PTCA and at
hospital discharge (HD - mean = 10 days). The end points were: analysis of
arterial patency rate at HD and its relation to ejection fraction (EF) recovery
and in pts with sustained arterial patency (SAPj, which ones exhibit a greater
increase in EF. P values < 0.05 were submitted to multivariate analysis (risk
adjustment).
Variable % Pre EF HD EF GAIN P
Arterial Patency 91 43 ± 9 49± 8 +6.1 ±4% 0.001'
Reocclusion 9 45 ± 8 41 ± 10 -3.4 ± 5%
ONLY PTS WITH SAP:
Anterior MI 52 41 ± 7 47 ± 9 +6.3 ± 4% 002
Inferior MI 48 49 ± 9 52 ± 10 +3.1 ± 2%
Ischemia time < 4 hrs 42 44± 8 53 ± 9 +9.4 ± 5% 0.001*
Ischemia time> 4 hrs 58 44± 9 49± 5 +5.1 ± 2%
Multivessel disease 52 42 ± 9 50 ± 7 +8.1 ± 4% 002
Single vessel disease 48 44± 10 48± 9 +3.9 ± 3%
Baseline EF < 40% 43 33 ± 9 42± 8 +9.6± 5% 0.001'
Baseline EF > 40% 57 51 ± 9 54 ± 5 +3.2 ± 1%
• 1I00CA.
Effects of L-Carnitine on Left Ventricular Function
After Acute Myocardial Infarction. Results of the
CEDIM (Carnitina Ecocardiografia Digitale Infarto
Miocardico) Trial
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Results: 3 months 6 months 12 months
L'l.%-EDV L-C 11.1 ± 30.2 12.7 ± 26.8 191 ± 36.2
PI 18.0 ± 33.0' 19.5 ± 30.6' 28.5 ± 402'
L'l.%-ESV L-C 12.6 ± 41.6 15.1 ± 368 289 ± 51.4
PI 22.5 ± 42.8' 256 ± 42.3" 39.9 ± 55.1'
Sabino Iliceto, Vito Marangelli, Giuseppe Santoro. Luca Bani.
Gaetano D'Ambrosio, Domenico Scrutinio, Paolo Bruzzi, Paul G. Hugenholtz,
Paolo Rizzon, CEDIM Investigators. Institute of Cardiology, Bari, Italy
Limitation of left ventricular (LV) dilatation (LV remodeling) after acute my-
ocardial infarction (AMI) has become an essential therapeutic goal since the
entity of LV dilatation after AMI is now recognized to be the most power-
ful prognostic predictor for clinical outcome. L-Carnitine (L-C) is an essential
compound of cardiac metabolism that favours the optimal utilization of en-
ergetic substrates. Experimental studies have demonstrated that L-C admin-
istration during and after myocardial ischemia restores L-C cardiac depletion
following ischemia and exerts a beneficial effect on LV function. To test the
hypothesis, that timely restoration of adequate intracardiac L-C levels after
AMI could limit LV dilatation on a long-term basis in a clinical setting, a mul-
ticenter, randomized, double-blind, placebo controlled trial was undertaken
(CEOIM trial). 472 pts with first, anterior AMI and high quality entry 20 echo
were enrolled (370/472 pts underwent thrombolysis). Pts were randomized
to placebo (PI) or L-C (6 g/day iv for the first 5 days and 9 g/day orally for the
following 12 months). 20 echo was digitally performed on admission, at 3,
6, 12 months after AMI. 2D echo images were transmitted via modem using
a long-distance network to a Core Laboratory where end-diastolic and end-
systolic volumes (EOV, ESV) were assessed. Baseline clinical and echocar-
diographic characteristics were similar in L-C and PI groups. Percent variation
(L'l. %) of EOV and ESV at 3, 6,12 months from baseline was evaluated in both
PI and L-C groups.
Conclusions; (i) The beneficial effect of lido on infarct size was associated
with a significant reduction in the accumulation of PMNs in the reperfused
rabbit myocardium. (ii) This beneficial effect may occur as a direct inhibitory
effect of lido on PMNs. (iii) This effect of lido on infarct size may also OCCur in
man as human cells respond similarly in vitro to equal doses of lidocaine. (iiii)
Lidocaine may confound the interpretation of other interventions to reduce
infarct size in animals and possibly in man.
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Congestive heart failure developed in 10 pts (4.2%) on PI vs 4 pts (1.7%) on
L-C. Conclusion; Timely administration of L-C after AM I limits LV dilatation in
the first year after AMI and, therefore, represents a new approach to optimize
LV remodeling after AMI.
Conclusions; Pts with SAP' and anterior Ml, multivessel disease, baseline
EF < 40%' and early reperfusion' are likely to benefit most from primary
PTCA in acute myocardial infarction ('independent variables).
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Christopher M. Speidel, Gerrald Galluppi 1, Dana R. Abendschein. Washington
University. St Louis, MO; 1 Monsanto/Searle, St. Louis, MO
Local administration of recombinant tissue factor pathway inhibitor (rTF PI).
the physiologic inhibitor of the tissue factor-factor Vila complex that also in-
hibits factor Xa, attenuates necrosis after reperfusion of ischemic ears in rab-
Fluosol Reduces Myocardial Reperfusion Injury by
Prolonged Suppression of Neutrophils by its
Detergent Component (RheothRx) and not by
Enhancing 02 Delivery
Joao V. Vitola, David A. Ingram, John P. Holsinger, James B. Atkinson, Mervyn
B. Forman, John J. Murray. Vanderbilt University. Nashville. TN
Fluosol, a complex mixture of 02 carrying perfluorocarbons (PFCs) emu lsi-
1923-51 Tissue Factor Pathway Inhibitor Decreases
Myocardial Reperfusion Injury in Dogs
